159 related articles for article (PubMed ID: 17390012)
1. High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas.
Saussez S; Decaestecker C; Lorfevre F; Cucu DR; Mortuaire G; Chevalier D; Wacreniez A; Kaltner H; André S; Toubeau G; Camby I; Gabius HJ; Kiss R
Int J Oncol; 2007 May; 30(5):1109-17. PubMed ID: 17390012
[TBL] [Abstract][Full Text] [Related]
2. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas.
Saussez S; Decaestecker C; Lorfevre F; Chevalier D; Mortuaire G; Kaltner H; André S; Toubeau G; Gabius HJ; Leroy X
Histopathology; 2008 Mar; 52(4):483-93. PubMed ID: 18315601
[TBL] [Abstract][Full Text] [Related]
3. Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7.
Saussez S; Cludts S; Capouillez A; Mortuaire G; Smetana K; Kaltner H; André S; Leroy X; Gabius HJ; Decaestecker C
Int J Oncol; 2009 Feb; 34(2):433-9. PubMed ID: 19148478
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 upregulation during tumor progression in head and neck cancer.
Saussez S; Decaestecker C; Mahillon V; Cludts S; Capouillez A; Chevalier D; Vet HK; André S; Toubeau G; Leroy X; Gabius HJ
Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282
[TBL] [Abstract][Full Text] [Related]
5. Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectin-1, -3 and -7.
Cludts S; Decaestecker C; Mahillon V; Chevalier D; Kaltner H; André S; Remmelink M; Leroy X; Gabius HJ; Saussez S
Anticancer Res; 2009 Dec; 29(12):4933-40. PubMed ID: 20044599
[TBL] [Abstract][Full Text] [Related]
6. The helicase-like transcription factor is a strong predictor of recurrence in hypopharyngeal but not in laryngeal squamous cell carcinomas.
Capouillez A; Debauve G; Decaestecker C; Filleul O; Chevalier D; Mortuaire G; Coppée F; Leroy X; Belayew A; Saussez S
Histopathology; 2009 Jul; 55(1):77-90. PubMed ID: 19614770
[TBL] [Abstract][Full Text] [Related]
7. Adhesion/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis/lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas.
Saussez S; Decaestecker C; Cludts S; Ernoux P; Chevalier D; Smetana K; André S; Leroy X; Gabius HJ
Anticancer Res; 2009 Jan; 29(1):59-65. PubMed ID: 19331133
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
[TBL] [Abstract][Full Text] [Related]
9. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer.
Saussez S; Cucu DR; Decaestecker C; Chevalier D; Kaltner H; André S; Wacreniez A; Toubeau G; Camby I; Gabius HJ; Kiss R
Ann Surg Oncol; 2006 Jul; 13(7):999-1009. PubMed ID: 16788763
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1: a link between tumor hypoxia and tumor immune privilege.
Le QT; Shi G; Cao H; Nelson DW; Wang Y; Chen EY; Zhao S; Kong C; Richardson D; O'Byrne KJ; Giaccia AJ; Koong AC
J Clin Oncol; 2005 Dec; 23(35):8932-41. PubMed ID: 16219933
[TBL] [Abstract][Full Text] [Related]
11. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma.
Honjo Y; Inohara H; Akahani S; Yoshii T; Takenaka Y; Yoshida J; Hattori K; Tomiyama Y; Raz A; Kubo T
Clin Cancer Res; 2000 Dec; 6(12):4635-40. PubMed ID: 11156213
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma.
Plzák J; Betka J; Smetana K; Chovanec M; Kaltner H; André S; Kodet R; Gabius HJ
Eur J Cancer; 2004 Oct; 40(15):2324-30. PubMed ID: 15454259
[TBL] [Abstract][Full Text] [Related]
13. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the expression of galectin-3 and Pim-1 in laryngeal squamous cell carcinoma.
Choi JY; Cho SI; Do NY; Kang CY; Lim SC
J Otolaryngol Head Neck Surg; 2010 Feb; 39(1):28-34. PubMed ID: 20122341
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic HuR over-expression is associated with increased cyclooxygenase-2 expression in laryngeal squamous cell carcinomas.
Cho NP; Han HS; Soh Y; Lee KY; Son HJ
Pathology; 2007 Dec; 39(6):545-50. PubMed ID: 18027256
[TBL] [Abstract][Full Text] [Related]
16. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
[TBL] [Abstract][Full Text] [Related]
17. Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting.
Nagy N; Legendre H; Engels O; André S; Kaltner H; Wasano K; Zick Y; Pector JC; Decaestecker C; Gabius HJ; Salmon I; Kiss R
Cancer; 2003 Apr; 97(8):1849-58. PubMed ID: 12673710
[TBL] [Abstract][Full Text] [Related]
18. Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas.
Liu B; Ren Z; Shi Y; Guan C; Pan Z; Zong Z
Laryngoscope; 2008 Nov; 118(11):1976-80. PubMed ID: 18758380
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of the cyclin E in laryngeal carcinomas].
Gao H; Li L; Peng S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 23(6):254-5. PubMed ID: 19621596
[TBL] [Abstract][Full Text] [Related]
20. Fas expression is associated with a better prognosis in laryngeal squamous cell carcinoma.
Asensio C; Zapata A; García-Ahijado J; Gil B; Salvadores P; Schneider J
Anticancer Res; 2007; 27(6B):4083-6. PubMed ID: 18225575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
